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Background: The coronavirus disease 2019 (COVID-19) pandemic
has challenged the accuracy and racial biases present in traditional
mortality scores. An accurate prognostic model that can be applied to
hospitalized patients irrespective of race or COVID-19 status may
beneﬁt patient care.

model achieved an area under the receiver operating characteristic
curve of 0.89 (95% conﬁdence interval: 0.88, 0.91) and an average
positive predictive value of 0.46 (0.40, 0.52). Model performance
did not differ signiﬁcantly in White (0.89) and non-White (0.90)
subgroups or when grouping by COVID-19 status and intensive care
unit admission.

Research Design: This cohort study utilized historical and ongoing
electronic health record features to develop and validate a deeplearning model applied on the second day of admission predicting a
composite outcome of in-hospital mortality, discharge to hospice, or
death within 30 days of admission. Model features included patient
demographics, diagnoses, procedures, inpatient medications, laboratory values, vital signs, and substance use history. Conventional
performance metrics were assessed, and subgroup analysis was
performed based on race, COVID-19 status, and intensive care unit
admission.

Conclusion: A deep-learning model using large-volume, structured
electronic health record data can effectively predict short-term
mortality or hospice outcomes on the second day of admission in the
general inpatient population without signiﬁcant racial bias.

Subjects: A total of 35,521 patients hospitalized between April 2020
and October 2020 at a single health care system including a tertiary
academic referral center and 9 community hospitals.

T

Results: Of 35,521 patients, including 9831 non-White patients and
2020 COVID-19 patients, 2838 (8.0%) met the composite outcome.
Patients who experienced the composite outcome were older (73 vs.
61 y old) with similar sex and race distributions between groups. The
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he health care crisis caused by coronavirus disease 2019
(COVID-19) has highlighted deﬁciencies in current
mortality prediction tools. As a critical endpoint for patients
and physicians alike, mortality has been the subject of numerous clinical prediction models. Independent evaluation
has found signiﬁcant heterogeneity in accuracy and withinmodel variability, however, with many predictive tools
demonstrating only modest discrimination, low clinical utility, and high risk of racial bias.1–6 These limitations were
further underscored by COVID-19, which forced many institutions to implement triage policies under crisis standards
of care. Over 80% of hospitals with formal triage policies
used a version of the Sequential Organ Failure Assessment
score, which was later found to both systematically prioritize
White patients over Black patients while also demonstrating
lower discriminant accuracy than simply using patient age to
predict mortality in ventilated COVID-19 patients.7–9 Even as
health care systems look to move past COVID-19, novel
methods to estimate mortality without racial bias are clearly
needed.
To address this prognostic challenge, researchers and
clinicians have increasingly turned to machine learning (ML).
With the ability to model complex interactions between diverse clinical datasets, ML models show superior performance to conventional mortality risk scores in diseases such
as sepsis or heart failure.10,11 Comparatively few studies
attempt to apply ML to inpatient mortality, however,
with limited generalizability driven by technical design,
www.lww-medicalcare.com
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FIGURE 1. Deep learning model structure. Three bidirectional long short-term memory (LSTM) models were constructed to
analyze clinical variables grouped by data type: 100 most recent diagnosis, procedure, and medication codes (A); 150 most recent
laboratory test names and values (B); 300 most recent vital sign names and values (C). A fourth neural network model (D) was
comprised of demographic and social history variables.

heterogenous populations, and potential for racial bias that
has gone largely uninvestigated.6,12–17 The data used to train
these models also predate the COVID-19 pandemic, which
impacted health care delivery and outcomes nationwide.18–22
The utility of ML in predicting mortality outcomes of hospitalized patients in the modern COVID-19 era therefore
remains to be demonstrated.
We have previously shown that a long short-term
memory (LSTM) deep-learning model trained on electronic
health record (EHR) and claims data was effective at predicting mortality relative to 3 other common ML
approaches.23 LSTM are a type of recurrent neural network
that analyzes time-sorted data in the context of surrounding
values; among other advantages, this property allows LSTM
to learn from trends in patient data, thereby mimicking clinical practice. By consolidating the model to EHR-speciﬁc
features and adding time-dependent variables, speciﬁcally
vital signs and laboratory results from the patient’s ﬁrst
TABLE 1. Study Population Characteristics

hospital day, we sought to create an accurate, racially unbiased deep-learning model which would be readily
integrated into the EHR for real-time clinical application.

METHODS
Data Source
Patient data were collected from admissions to 10
academic and community-based hospitals within the BJC
HealthCare system from April 2020 to October 2020. This
health care system covers a diverse catchment area across
mid-Missouri, Southern Illinois, and greater Saint Louis regions, and includes a 1250-bed tertiary referral center as well
as multiple community hospitals. Hospitalizations longer than
24 hours were included for feature extraction. Admissions to
psychiatry, labor/delivery, and bone marrow transplant units
were excluded. This project was approved by the Washington
University in Saint Louis Institutional Review Board; need
for informed consent was waived.

n (%)

Characteristics

No Mortality/
Hospice
Outcome

No. patients
32,682 (92.0)
Age [mean (SD)]
61.2 (17.5)
Sex
Male
16,191 (49.5)
Female
16,490 (50.5)
Unknown
1 (0.0)
Race
White
23,616 (72.3)
Black
8438 (25.8)
Asian
257 (0.8)
Other
371 (1.1)
COVID-19 status
COVID-19 (+)
1587 (4.9)
COVID-19 (–)
31,095 (95.1)
ICU admission in ﬁrst 24 h
ICU (+)
4475 (13.7)
ICU (–)
28,207 (86.3)

Mortality/
Hospice
Outcome

Cohort and Study Design
Total

2839 (8.0)
72.6 (15.0)

35,521
62.1 (17.6)

1451 (51.1)
1388 (48.9)
0 (0.0)

17,642 (49.7)
17,878 (50.3)
1 (0.0)

2074
669
22
74

25,690
9107
279
445

(73.1)
(23.6)
(0.8)
(2.6)

433 (15.3)
2406 (84.7)

2020 (5.7)
33,501 (94.3)

1089 (38.4)
1750 (61.6)

5564 (15.7)
29,957 (84.3)

COVID-19 indicates coronavirus disease 2019; ICU, intensive care unit.
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(72.3)
(25.6)
(0.8)
(1.0)

Of 46,206 admissions with hospitalizations longer than
24 hours and identiﬁable mortality outcomes within 30 days,
a total of 35,521 unique patients were included in the analysis. For patients with multiple admissions, one admission
was selected randomly for feature extraction to reduce selection bias. The primary outcome of interest was in-hospital
mortality, discharge to hospice, or death within 30 days of
admission.
Subgroup analysis was performed in 3 patient subgroups to evaluate model accuracy and bias. These subgroups
were deﬁned by COVID-19 status, intensive care unit (ICU)
admission within the ﬁrst 24 hours of hospitalization, and
race (White and non-White). To account for external COVID19 testing and processing time for internal COVID-19 assays,
COVID-19 status was determined retrospectively based on
either a positive test result for COVID-19 or infection prevention ﬂags specifying conﬁrmed COVID-19 infection
during the index admission.

Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc.
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Feature Extraction
All encounter records for each patient available up to
24 hours after time of admission were extracted from the
EHR. Features included demographics, diagnosis codes,
procedure codes, inpatient medication lists, laboratory results,
vital signs, and social history. All features were sorted in a
time increasing order.
Diagnosis, procedure, and medication codes were mapped
to a 32-dimensional vector space using the Word2Vec
technique.24 The Python Genism Word2Vec model employed
the following hyperparameters: size (embedding dimension) of
32, window (the maximum distance between a target word and
all words around it) of 5, min_count (the minimum number of
words counted when training the model) of 1, and the sg
(training algorithm) was CBOW (continuous bag of words).
Each feature was then represented by a 32-dimensional
numerical vector.

Deep-learning Model Development
Patient features were structured into 4 groups for input into the deep-learning model: (1) embedding vectors of
diagnosis codes, procedure codes, and medication codes
with a dimension of (100, 32), where 100 denoted the most
recent 100 codes and 32 was the dimension of embedding
vectors; (2) numerical variables from laboratory results with
a dimension of (150, 2), where 150 was the number of most
recent laboratory records, and 2 was the test names and
related values; (3) numerical variables from vital signs with
a dimension of (300, 2), where 300 was the number of most
recent vital sign records, and 2 was the vital sign names and
related values; and (4) demographic and social history
variables with a dimension of 16, which represented age
and categorical variables such as sex, COVID-19 infection
status, ICU admission, and substance use history.
The deep-learning model was comprised of 3 bidirectional LSTM models and a fourth neural network model representing the above groups (Fig. 1). A binary cross-entropy

Modern Machine Learning Mortality Model

loss function was employed as the output layer and a Sigmoid
function was used as the activation function for the hidden
layer. An Adam optimizer was used to optimize the model with
a mini-batch size of 256 samples.

Data Splits and Model Evaluation
Patients were randomly divided into training (80%),
validation (10%), and testing (10%) datasets for a total of
28,417 patients in the training data set and 3552 patients each
in the validation and testing datasets. Model performance was
evaluated in the overall cohort and each subgroup using
standard performance metrics as well as receiver operating
characteristic (ROC) and precision-recall curves. Precision-recall curves compare a model’s positive predictive value (PPV
or precision) against its sensitivity (recall) as the discrimination
threshold is varied. In contrast to ROC curves which utilize the
false positive rate instead of PPV, precision-recall curves are
not dependent on the number of true negative cases and may
therefore be more informative for imbalanced datasets with a
low expected outcome rate. Ninety-ﬁve percent conﬁdence
intervals were calculated for each metric. The model was also
tested under a series of discrimination thresholds or cutoffs,
ranging from 0.1 to 0.9.

RESULTS
The observed rate of the composite outcome of inhospital mortality, discharge to hospice, or death within
30 days of admission was 8%. Patients who met the composite outcome were older (73 vs. 61 y) with similar sex and
race distributions between groups (Table 1). Patients with
COVID-19 infection were more likely to experience the
mortality/hospice outcome than patients without COVID-19
(21% vs. 7%). Thirty-eight percent of patients who met the
mortality/hospice outcome were admitted to an ICU within
the ﬁrst 24 hours of admission.
ROC and precision-recall curves were constructed to evaluate model performance in the overall cohort and patient subgroups

FIGURE 2. Deep learning model prediction performance. Area under the receiver operating characteristic and precision-recall
curves for model performance in the overall cohort. Shaded areas denote 95% CIs. AUC indicates area under the curve; CI,
confidence interval.
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc.
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FIGURE 3. Deep learning model performance in clinical subgroups. Area under the receiver operating characteristic and precisionrecall curves for model performance in clinical subgroups. COVID-positive patients were classified retrospectively based on either a
positive COVID-19 test result or infection prevention flags specifying confirmed COVID-19 infection during the index admission.
ICU+ was defined by patients admitted to an ICU within the first 24 hours of hospitalization. Brackets indicate 95% confidence
intervals. AUC indicates area under the curve; COVID-19, coronavirus disease 2019; ICU, intensive care unit.
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(Figs. 2, 3). In the overall study cohort, the area under the ROC
curve was 0.89 (0.88, 0.91). The area under the precision-recall
curve was 0.46 (0.40, 0.52), corresponding to an average model
PPV of 46% compared with the observed outcome rate of 8%.
Table 2 lists the model’s performance metrics at different
thresholds of predicted probabilities. The F1 score, which is the
harmonic mean of PPV and sensitivity, plateaued at thresholds up
to 0.3; this cutoff corresponded to a sensitivity of 0.38 (0.32, 0.43),
speciﬁcity of 0.97 (0.97, 0.97), and PPV of 0.54 (0.46, 0.61).
In the prespeciﬁed patient subgroups, area under the
ROC curve did not differ signiﬁcantly by COVID-19 status
[0.89 (0.83, 0.94) vs. 0.89 (0.87, 0.91)], ICU [0.86 (0.82,
0.89)] versus non-ICU admission [0.88 (0.86, 0.91)], or
Whites [0.89 (0.87, 0.91)] compared with non-Whites [0.90
0.86, 0.94)]. Average model PPV was higher in the COVID19 positive [0.68 (0.52, 0.81)] and ICU admission [0.71
(0.52, 0.69)] subgroups. Subgroup model performance by
cutoffs was also evaluated (Supplemental Table 1, Supplemental Digital Content 1, http://links.lww.com/MLR/C412);
when using a threshold risk score of 0.3, positive predictive
value exceeded 50% and speciﬁcity was > 90% in every
subgroup.

DISCUSSION
In this study, we developed and validated a structured deeplearning model using EHR-speciﬁc data from academic and
community hospitals to predict in-hospital mortality, discharge to
hospice, or death within 30 days of admission. The model incorporated both historical and acute variables in the patient’s
medical record to generate a numerical risk score on the second
day of admission for clinical use. This ML approach was shown to
have excellent predictive value with no signiﬁcant differences in
performance based on race or COVID-19 status.
Our investigation has several unique strengths and limitations. The model was trained on data from the ﬁrst 7 months of
the COVID-19 pandemic, during which health care delivery was
severely impacted in the form of treatment delays, experimental
interventions, and crisis standards of care seen at many
facilities.18–22,25–29 This clinical variability would be expected to
diminish the accuracy of any prediction tool, yet our model
showed favorable performance metrics and no signiﬁcant racial
bias in comparison to many previously published traditional and
ML mortality scores.1,6,9 This ﬁnding may be attributed to the
structure and scope of our deep-learning model. An average of
over 500continuous, categorical, and multidimensional variables
per patient were incorporated into a framework of LSTM models,

which may be more effective than other ML techniques at predicting mortality.23 Compared with other mortality scores that
include only acute gical or disease-speciﬁc data, this multifaceted
approach to feature inclusion leverages the full breadth of data
available in modern EHRs, thereby providing a more comprehensive picture of patient health.6,10,30 This reliance on “big data”
decreases our model’s transparency, however, as the factors
contributing to a patient’s score within the LSTM hierarchy are not
readily visible. This lack of interpretability is a signiﬁcant limitation shared by other ML models intended for clinical
implementation.31 Future steps to improve model transparency,
such as feature importance analysis, will be required to maximize
clinical utilization.
Our model was developed using data from a single health
care system, which poses a signiﬁcant challenge to portability due
to EHR and population heterogeneity. While direct replication of
our model may not be feasible, however, we would argue that our
study population and model design support generalization of
similarly structured ML models to other centers. The training data
set included a diverse patient population spread across medical,
surgical, and subspecialty ﬂoors and ICUs at academic and community hospitals encompassing a large geographic area. Urban,
suburban, and rural counties were included along with signiﬁcant
non-White representation. The model structure does not require
any manual curation or preprocessing of patient features, which
can dramatically increase cost and computational time, and the use
of EHR-speciﬁc data has enabled complete integration of the
model into our institution’s EHR.32 Risk scores are now generated
automatically on all inpatients without any user input for real-time
clinical use. While implementation will necessarily vary between
centers, we hope other institutions see this model as a proofof-concept for the potential of LSTM models to yield accurate,
racially unbiased predictions in the COVID-19 era.
Clinical applications of this mortality model are the subject
of ongoing investigations. Our model demonstrated excellent
positive predictive value in all clinical subgroups, supporting its
clinical relevance as a mortality screening tool.33 For example, a
screening threshold of 0.3, corresponding to a minimum 30% risk
of inpatient mortality, hospice discharge, or death within 30 days
of admission, would identify at-risk patients with > 50% PPV and
90% speciﬁcity. Clinical care can then be enhanced for those
patients through increased clinical attention or advance care
planning discussions. One promising application is through directed palliative care, which has been previously shown to decrease ICU transfers, increase advance care planning, and facilitate
goal-concordant limitations in care.34–36 With multiple recent
studies highlighting the potential of improving palliative care

TABLE 2. Performance Metrics by Cutoff Values (95% Confidence Interval)
Cutoffs
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9

Accuracy
0.86
0.91
0.93
0.93
0.93
0.93
0.93
0.93
0.93

(0.84, 0.87)
(0.9, 0.92)
(0.92, 0.94)
(0.92, 0.93)
(0.92, 0.94)
(0.92, 0.94)
(0.92, 0.93)
(0.92, 0.93)
(0.92, 0.93)

Sensitivity
0.76
0.52
0.38
0.23
0.13
0.1
0.05
0.02
0.0

(0.71, 0.81)
(0.46, 0.57)
(0.32, 0.43)
(0.18, 0.27)
(0.09, 0.16)
(0.06, 0.13)
(0.02, 0.07)
(0.0, 0.04)
(0.0, 0.0)

Speciﬁcity
0.86
0.94
0.97
0.98
0.99
1.0
1.0
1.0
1.0

(0.86, 0.86)
(0.94, 0.94)
(0.97, 0.97)
(0.98, 0.98)
(0.99, 0.99)
(1.0, 1.0)
(1.0, 1.0)
(1.0, 1.0)
(1.0, 1.0)

Precision
0.32
0.42
0.54
0.55
0.64
0.76
0.81
1.0
0.0

Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc.

(0.28, 0.35)
(0.37, 0.47)
(0.46, 0.61)
(0.46, 0.65)
(0.51, 0.78)
(0.61, 0.89)
(0.6, 1.0)
(1.0, 1.0)
(0.0, 0.0)

F1 Score
0.45
0.46
0.44
0.32
0.21
0.17
0.09
0.04
0.0

(0.4, 0.49)
(0.41, 0.51)
(0.39, 0.5)
(0.26, 0.38)
(0.15, 0.27)
(0.11, 0.22)
(0.05, 0.14)
(0.01, 0.07)
(0.0, 0.0)

Negative Predictive Value
0.98
0.96
0.95
0.94
0.93
0.93
0.93
0.93
0.93

(0.98,
(0.96,
(0.95,
(0.94,
(0.93,
(0.93,
(0.93,
(0.93,
(0.93,

0.98)
0.96)
0.95)
0.94)
0.93)
0.93)
0.93)
0.93)
0.93)
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through deep learning, we plan to implement a targeted palliative
care intervention through the hospital-wide screening potential of
our model.37–39

CONCLUSIONS
A structured deep-learning model developed during the
COVID-19 pandemic accurately predicted in-hospital mortality,
discharge to hospice, or death within 30 days of admission among
inpatients at a large academic and community-based health care
system. Our study suggests that a single model can predict shortterm mortality outcomes of patients across multiple clinical subgroups with excellent predictive value and minimal racial bias.
Clinical applications of this inpatient mortality model are the targets
of ongoing investigation.
ACKNOWLEDGMENTS
The authors thank Joshua Landman for his assistance
with data management and analysis.
REFERENCES
1. Siontis GCM, Tzoulaki I, Ioannidis JPA. Predicting death: an empirical
evaluation of predictive tools for mortality. Arch Intern Med. 2011;171:
1721–1726.
2. Yourman LC, Lee SJ, Schonberg MA, et al. Prognostic indices for older
adults: a systematic review. JAMA. 2012;307:182–192.
3. Vigil JM, Coulombe P, Alcock J, et al. Patient ethnicity affects triage
assessments and patient prioritization in U.S. Department of Veterans
Affairs Emergency Departments. Medicine (Baltimore). 2016;95:e3191.
4. Ho LO, Li H, Shahidah N, et al. Poor performance of the modified early
warning score for predicting mortality in critically ill patients presenting
to an emergency department. World J Emerg Med. 2013;4:273–278.
5. Schrader CD, Lewis LM. Racial disparity in emergency department
triage. J Emerg Med. 2013;44:511–518.
6. Allen A, Mataraso S, Siefkas A, et al. A racially unbiased, machine
learning approach to prediction of mortality: algorithm development
study. JMIR Public Health Surveill. 2020;6:e22400.
7. Antommaria AHM, Gibb TS, McGuire AL, et al. Ventilator triage
policies during the COVID-19 pandemic at U.S. hospitals associated
with members of the Association of Bioethics Program Directors. Ann
Intern Med. 2020;173:188–194.
8. Raschke RA, Agarwal S, Rangan P, et al. Discriminant accuracy of the SOFA
score for determining the probable mortality of patients with COVID-19
pneumonia requiring mechanical ventilation. JAMA. 2021;325:1469–1470.
9. Ashana DC, Anesi GL, Liu VX, et al. Equitably allocating resources
during crises: racial differences in mortality prediction models. Am J
Respir Crit Care Med. 2021;204:178–186.
10. Guo A, Pasque M, Loh F, et al. Heart failure diagnosis, readmission, and
mortality prediction using machine learning and artificial intelligence
models. Curr Epidemiol Rep. 2020;7:212–219.
11. van Doorn WPTM, Stassen PM, Borggreve HF, et al. A comparison of
machine learning models versus clinical evaluation for mortality
prediction in patients with sepsis. PLoS One. 2021;16:e0245157.
12. Mohamadlou H, Panchavati S, Calvert J, et al. Multicenter validation of a
machine-learning algorithm for 48-h all-cause mortality prediction.
Health Informatics J. 2020;26:1912–1925.
13. Soffer S, Klang E, Barash Y, et al. Predicting in-hospital mortality at
admission to the medical ward: a big-data machine learning model. Am J
Med. 2021;134:227–234.e4.
14. Major VJ, Aphinyanaphongs Y. Development, implementation, and prospective validation of a model to predict 60-day end-of-life in hospitalized adults
upon admission at three sites. BMC Med Inform Decis Mak. 2020;20:214.
15. Brajer N, Cozzi B, Gao M, et al. Prospective and external evaluation of a
machine learning model to predict in-hospital mortality of adults at time
of admission. JAMA Netw Open. 2020;3:e1920733.

386 | www.lww-medicalcare.com



Volume 60, Number 5, May 2022

16. Escobar GJ, Gardner MN, Greene JD, et al. Risk-adjusting hospital
mortality using a comprehensive electronic record in an integrated health
care delivery system. Med Care. 2013;51:446–453.
17. Obermeyer Z, Powers B, Vogeli C, et al. Dissecting racial bias in an algorithm
used to manage the health of populations. Science. 2019;366:447–453.
18. Rosenbaum L. The untold toll—the pandemic’s effects on patients
without COVID-19. N Engl J Med. 2020;382:2368–2371.
19. Satty T, Ramgopal S, Elmer J, et al. EMS responses and non-transports
during the COVID-19 pandemic. Am J Emerg Med. 2021;42:1–8.
20. Ueberham L, König S, Pellissier V, et al. Admission rates and care
pathways in patients with atrial fibrillation during the COVID-19
pandemic—insights from the German-wide Helios Hospital Network.
Eur Heart J Qual Care Clin Outcomes. 2021;7:257–264.
21. Baum A, Schwartz MD. Admissions to Veterans Affairs hospitals for
emergency conditions during the COVID-19 pandemic. JAMA. 2020;
324:96–99.
22. Rizzi A, Mammarella L, Necozione S, et al. Looking at intra-hospital non
COVID-19 mortality among elderly patients during COVID-19 pandemic. Arch Gerontol Geriatr. 2020;90:104173.
23. Guo A, Foraker R, White P, et al. Using electronic health records and
claims data to identify high-risk patients likely to benefit from palliative
care. Am J Manag Care. 2021;27:e7–e15.
24. Mikolov T, Chen K, Corrado G, et al. Word2vec. Proc Int Conf Learn
Represent; 2013.
25. El-Solh AA, Lawson Y, Carter M, et al. Comparison of in-hospital
mortality risk prediction models from COVID-19. PLoS One. 2020;15:
e0244629.
26. Stasi C, Fallani S, Voller F, et al. Treatment for COVID-19: an overview.
Eur J Pharmacol. 2020;889:173644.
27. Zhang JJY, Lee KS, Ang LW, et al. Risk factors for severe disease and
efficacy of treatment in patients infected with COVID-19: a systematic
review, meta-analysis, and meta-regression analysis. Clin Infect Dis.
2020;71:2199–2206.
28. RECOVERY Collaborative Group, Horby P, Lim WS, et al. Dexamethasone in hospitalized patients with COVID-19. N Engl J Med.
2021;384:693–704.
29. Yokoyama Y, Briasoulis A, Takagi H, et al. Effect of remdesivir on
patients with COVID-19: a network meta-analysis of randomized control
trials. Virus Res. 2020;288:198137.
30. Khera R, Haimovich J, Hurley NC, et al. Use of machine learning models
to predict death after acute myocardial infarction. JAMA Cardiol. 2021;6:
633–641.
31. Markus AF, Kors JA, Rijnbeek PR. The role of explainability in creating
trustworthy artificial intelligence for health care: a comprehensive survey
of the terminology, design choices, and evaluation strategies. J Biomed
Inform. 2021;113:103655.
32. Sendak MP, Balu S, Schulman KA. Barriers to achieving economies of
scale in analysis of EHR data. Appl Clin Inform. 2017;08:826–831.
33. Steyerberg EW, Vickers AJ, Cook NR, et al. Assessing the performance
of prediction models: a framework for some traditional and novel
measures. Epidemiology. 2010;21:128–138.
34. Picker D, Dans M, Heard K, et al. A randomized trial of palliative care
discussions linked to an automated early warning system alert. Crit Care
Med. 2017;45:234–240.
35. Deptola AZ, Riggs J. Inpatient goals-of-care conversations reduce
intensive care unit transfers in high-risk patients. Am J Hosp Palliat
Care. 2019;36:583–586.
36. Ma J, Chi S, Buettner B, et al. Early palliative care consultation in the
medical ICU: a cluster randomized crossover trial. Crit Care Med.
2019;47:1707–1715.
37. Avati A, Jung K, Harman S, et al. Improving palliative care with deep
learning. BMC Med Inform Decis Mak. 2018;18(suppl 4):122.
38. Courtright KR, Chivers C, Becker M, et al. Electronic health record
mortality prediction model for targeted palliative care among hospitalized medical patients: a pilot quasi-experimental study. J Gen Intern
Med. 2019;34:1841–1847.
39. Murphree DH, Wilson PM, Asai SW, et al. Improving the delivery of
palliative care through predictive modeling and healthcare informatics.
J Am Med Inform Assoc. 2021;28:1065–1073.

Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc.

